BBIO ▼ -1.2% - BridgeBio Pharma, Inc.
$BBIO reported Q3 2026 EPS of -$0.42, beating the -$0.57 estimate by 26.3%. Revenue of $353.2M beat the $295.9M estimate by 19.3%.
29-OCT-2026 04:08 PM ET
Share this post
More filings for $BBIO
BBIO ▲ +0.4% - BridgeBio Pharma, Inc.Oct 29, 2026BBIO - BridgeBio Pharma, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026BBIO ▼ -0.5% - BridgeBio Pharma, Inc.Oct 22, 2026BBIO ▲ +0.5% - BridgeBio Pharma, Inc.Oct 11, 2026BBIO ▲ +2.0% - BridgeBio Pharma, Inc.Oct 6, 2026BBIO ▲ +2.0% - BridgeBio Pharma, Inc.Oct 6, 2026
View full $BBIO filing history →💬 Comments
Loading comments…
Leave a comment